DK597687D0 - Imidazolidinonforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat dermed - Google Patents

Imidazolidinonforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat dermed

Info

Publication number
DK597687D0
DK597687D0 DK597687A DK597687A DK597687D0 DK 597687 D0 DK597687 D0 DK 597687D0 DK 597687 A DK597687 A DK 597687A DK 597687 A DK597687 A DK 597687A DK 597687 D0 DK597687 D0 DK 597687D0
Authority
DK
Denmark
Prior art keywords
group
preparing
same
imidazolidinone
procedures
Prior art date
Application number
DK597687A
Other languages
English (en)
Other versions
DK597687A (da
Inventor
Mikio Takeda
Masaru Inage
Hiroshi Wada
Hajime Tamaki
Takashi Ochiai
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of DK597687D0 publication Critical patent/DK597687D0/da
Publication of DK597687A publication Critical patent/DK597687A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK597687A 1986-11-14 1987-11-13 Imidazolidinonforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat dermed DK597687A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27265586 1986-11-14

Publications (2)

Publication Number Publication Date
DK597687D0 true DK597687D0 (da) 1987-11-13
DK597687A DK597687A (da) 1988-05-15

Family

ID=17516947

Family Applications (1)

Application Number Title Priority Date Filing Date
DK597687A DK597687A (da) 1986-11-14 1987-11-13 Imidazolidinonforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat dermed

Country Status (16)

Country Link
US (1) US4886817A (da)
EP (1) EP0268229B1 (da)
JP (1) JPS63239281A (da)
KR (1) KR930002488B1 (da)
CN (1) CN1017245B (da)
AT (1) ATE78033T1 (da)
AU (1) AU597444B2 (da)
CA (1) CA1304376C (da)
DE (1) DE3780259T2 (da)
DK (1) DK597687A (da)
ES (1) ES2046193T3 (da)
FI (1) FI90869C (da)
GR (1) GR3005227T3 (da)
HU (1) HU198199B (da)
IE (1) IE61446B1 (da)
IL (1) IL84409A (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600430A (en) * 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
GB9224144D0 (en) * 1992-11-18 1993-01-06 Erba Carlo Spa Phenyl-imidazolidinone derivatives and process for their preparation
JP3916092B2 (ja) * 1993-09-17 2007-05-16 杏林製薬株式会社 イミダゾリジノン誘導体とその酸付加塩及び老年性痴呆症の治療薬
US7129359B2 (en) 2002-07-09 2006-10-31 National Health Research Institutes Imidazolidinone compounds
CN101254189A (zh) * 2003-07-11 2008-09-03 埃尔比昂股份公司 用对苯并二氮杂䓬受体的α3亚基具有选择性的化合物治疗或预防中枢神经系统病症的方法
WO2005082054A2 (en) * 2004-02-26 2005-09-09 Sosei Co., Ltd. Combinations for the treatment of fungal infections
US7259174B2 (en) * 2004-05-25 2007-08-21 National Health Research Institutes Imidazolidinone compounds
WO2006078698A1 (en) * 2005-01-19 2006-07-27 Cengent Therapeutics, Inc. 2-imidazolone and 2-imidazolidinone heterocyclic inhibitors of tyrosine phosphatases
WO2007085357A1 (en) * 2006-01-30 2007-08-02 Euro-Celtique S.A. Cyclourea compounds as calcium channel blockers
KR20110077006A (ko) 2006-08-15 2011-07-06 노파르티스 아게 증가된 지질 수준과 관련된 질환의 치료에 적합한 헤테로시클릭 화합물
AU2013206248B2 (en) * 2008-06-27 2016-06-23 Xenon Pharmaceuticals Inc. Organic compounds
US8420661B2 (en) * 2010-04-13 2013-04-16 Hoffmann-La Roche Inc. Arylethynyl derivatives
CN102840229B (zh) * 2012-08-31 2015-11-18 中国舰船研究设计中心 可调心螺旋桨轴承装置
UA116023C2 (uk) * 2013-07-08 2018-01-25 Ф. Хоффманн-Ля Рош Аг Етинільні похідні як антагоністи метаботропного глутаматного рецептора
UA118035C2 (uk) * 2013-10-07 2018-11-12 Сінгента Партісіпейшнс Аг Гербіцидні сполуки
MA42508B1 (fr) 2015-06-03 2020-05-29 Hoffmann La Roche Dérivés d'éthynyle

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ184081A (en) * 1976-06-01 1980-10-08 Velsicol Chemical Corp 1-thiazol-2-yl-1 3-imidazolidn-2-ones
US4604127A (en) * 1984-07-17 1986-08-05 Eli Lilly And Company Herbicidal pyridazinylimidazolidinone compounds
JPS6133172A (ja) * 1984-07-24 1986-02-17 Kotobuki Seiyaku Kk 1,3−置換−2−イミダゾリジノン誘導体,胃腸運動亢進剤及びその製造方法
AU568789B2 (en) * 1985-02-22 1988-01-07 Mitsui Toatsu Chemicals Inc. 3,3'-dinitrodiphenylether from m-dinitrobenzene
US4600430A (en) * 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
JPH06133172A (ja) * 1992-10-20 1994-05-13 Fujitsu General Ltd ファクシミリ装置

Also Published As

Publication number Publication date
IE61446B1 (en) 1994-11-02
AU8112587A (en) 1988-05-19
FI874865A0 (fi) 1987-11-04
IL84409A0 (en) 1988-04-29
FI90869B (fi) 1993-12-31
KR930002488B1 (ko) 1993-04-02
CA1304376C (en) 1992-06-30
HU198199B (en) 1989-08-28
HUT45983A (en) 1988-09-28
IL84409A (en) 1991-12-15
JPH05396B2 (da) 1993-01-05
JPS63239281A (ja) 1988-10-05
CN87107864A (zh) 1988-08-31
AU597444B2 (en) 1990-05-31
EP0268229A3 (en) 1990-09-19
DK597687A (da) 1988-05-15
EP0268229B1 (en) 1992-07-08
ES2046193T3 (es) 1994-02-01
ATE78033T1 (de) 1992-07-15
KR880006231A (ko) 1988-07-22
DE3780259D1 (de) 1992-08-13
EP0268229A2 (en) 1988-05-25
DE3780259T2 (de) 1992-12-24
FI874865A (fi) 1988-05-15
IE873063L (en) 1988-05-14
FI90869C (fi) 1994-04-11
GR3005227T3 (da) 1993-05-24
CN1017245B (zh) 1992-07-01
US4886817A (en) 1989-12-12

Similar Documents

Publication Publication Date Title
DK597687A (da) Imidazolidinonforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat dermed
IS1564B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
FI901421A0 (fi) N-(3-hydroxi-4-piperidinyl) (dihydrobenzofuran, dihydro-2h-benzopyran- eller dihydrobenzodioxin) karboxiamidderivat.
IE45256L (en) Quinazolone derivatives
ATE89547T1 (de) Dopamin-vorlaeufer.
ATE92036T1 (de) Kardiovaskulaer aktive verbindungen.
NO172118C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt n-(omega-substituert -alkyl)-n'-((imidazol-4-yl)alkyl)-guanidin
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
DE68904102D1 (de) Antivirale tetrahydroimidazo(1,4)benzodiazepin-2-one.
DE3584608D1 (de) Amidabkoemmlinge.
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
IL106107A (en) Imidazolyl-substituted cyclohexane derivatives, their preparation and pharmaceutical compositions containing them
ES543797A0 (es) Procedimiento de preparacion de nuevos derivados benzohi- drilpiperacinos y sus sales de adicion acidas
DK165967C (da) Anvendelse af en 2-oxo-imidazolidinforbindelse til fremstilling af et farmaceutisk praeparat
ES8607968A1 (es) Un derivado de tetrahidro- -carbolina
ATE92037T1 (de) Kardiovaskulaer aktive verbindungen.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment